Q1 2021 Putnam Emerging Markets Equity Fund Q&A
- The fund outperformed for the 1-, 3-, 5-, 10-year, and life-of-fund periods ended March 31, 2021.
- In our view, the 10% pullback in March was a buying opportunity, and emerging-market equities remain poised to deliver strong performance.
- China is producing more patents and Ph.D.s than the United States, which we believe will foster the creation of some of the most successful companies in the 2020s.
How did the fund perform in the first quarter?For the first quarter, the fund underperformed its benchmark, the MSCI Emerging Markets Index [ND]. However, it outperformed the benchmark by a considerable margin for the 1-year period ended March 31, 2021. It also outper-formed for the 3-, 5-, 10-year, and life-of-fund periods.
Emerging-market stocks suffered sharp declines late in the quarter. What is your view on this and overall conditions?In our view, the 10% pullback in March was a buying opportunity. We believe emerging-market equities remain poised to deliver strong performance for three key reasons. First, they offer attractive relative and absolute valuations. Emerging-market equities are trading at a significant discount to the S&P 500, and many of these businesses offer a much stronger growth outlook than their U.S. counterparts, in our view. Second, we have supportive interest rates and liquidity. For example, interest rates in Brazil are just 2%, down from 14% four years ago. We believe this will drive a re-rating in equities and an acceleration in capital expenditures for businesses in Brazil. We expect this theme to play out in several other key emerging markets.
Finally, and most important, earnings-per-share growth is accelerating. Emerging-market GDP growth is likely to be 5%+, versus normalized levels of 2% growth in the developed world. And China is now producing more patents and Ph.D.s than the United States, which we believe will foster the creation of some of the most successful companies in the 2020s.
What is your outlook, and how are you positioning the portfolio as we begin a new quarter?The rollout of new Covid-19 vaccines is under way in many countries, including China, the world’s second-largest economy. Financial markets are anticipating widespread distribution of vaccines by mid-2021. Emerging-market stocks are expected to benefit from their focus on commodity exports, which should get a boost from strong Chinese economic growth and a weaker U.S. dollar.
Our strategy emphasizes bottom-up stock selection across geographies and sectors, with a focus on high-quality companies with strong balance sheets. We tend to avoid countries, companies, and currencies that we believe are more vulnerable to external macroeconomic shocks. We believe this approach has helped us add value to the portfolio, especially in the periods of increased market turbulence we’ve seen since early 2020.
For informational purposes only. Not an investment recommendation.
This material is provided for limited purposes. It is not intended as an offer or solicitation for the purchase or sale of any financial instrument, or any Putnam product or strategy. References to specific asset classes and financial markets are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations or investment advice. The opinions expressed in this article represent the current, good-faith views of the author(s) at the time of publication. The views are provided for informational purposes only and are subject to change. This material does not take into account any investor’s particular investment objectives, strategies, tax status, or investment horizon. Investors should consult a financial advisor for advice suited to their individual financial needs. Putnam Investments cannot guarantee the accuracy or completeness of any statements or data contained in the article. Predictions, opinions, and other information contained in this article are subject to change. Any forward-looking statements speak only as of the date they are made, and Putnam assumes no duty to update them. Forward-looking statements are subject to numerous assumptions, risks, and uncertainties. Actual results could differ materially from those anticipated. Past performance is not a guarantee of future results. As with any investment, there is a potential for profit as well as the possibility of loss.
Diversification does not guarantee a profit or ensure against loss. It is possible to lose money in a diversified portfolio.
Consider these risks before investing: International investing involves certain risks, such as currency fluctuations, economic instability, and political developments. Investments in small and/or midsize companies increase the risk of greater price fluctuations. Bond investments are subject to interest-rate risk, which means the prices of the fund’s bond investments are likely to fall if interest rates rise. Bond investments also are subject to credit risk, which is the risk that the issuer of the bond may default on payment of interest or principal. Interest-rate risk is generally greater for longer-term bonds, and credit risk is generally greater for below-investment-grade bonds, which may be considered speculative. Unlike bonds, funds that invest in bonds have ongoing fees and expenses. Lower-rated bonds may offer higher yields in return for more risk. Funds that invest in government securities are not guaranteed. Mortgage-backed securities are subject to prepayment risk. Commodities involve the risks of changes in market, political, regulatory, and natural conditions. You can lose money by investing in a mutual fund.
Putnam Retail Management.